GLP-1 & Weight

Switching From Semaglutide to Tirzepatide: Timing and Starting Dose

There is no equivalent mg map between semaglutide and tirzepatide, so most protocols restart at 2.5 mg and climb a 4-week ladder.

Michael Manevich4 min read

Semaglutide and tirzepatide are different molecules, so the milligrams do not line up. A person on 1 mg of semaglutide cannot just match that number on tirzepatide. The two drugs hit different receptors at different strengths, and the standard reference protocols treat tirzepatide as a fresh start rather than a continuation.

That is the core idea for switching from semaglutide to tirzepatide: there is no equivalent mg map. Most published titration schedules restart at the lowest tirzepatide step and climb from there. This article covers the timing, the typical starting dose, and the 4-week ladder, with worked unit math you can check in the tirzepatide calculator.

Why milligrams do not convert

Semaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GIP and GLP-1 agonist. Because the mechanisms differ, milligram strength is not interchangeable. Reference labeling for both molecules lists their own separate dose ladders, and neither defines a conversion factor to the other. So 0.5 mg of one is not 0.5 mg of the other in any meaningful sense.

For background on the two molecules side by side, see semaglutide vs tirzepatide and the tirzepatide to semaglutide conversion note, which both explain why a clean mg map does not exist.

The standard restart: 2.5 mg

The common reference starting step for tirzepatide is 2.5 mg once weekly, regardless of where someone finished on semaglutide. This lowest step is generally framed as an introduction dose used to let the body adjust before any increase. Starting low is the same logic used for a brand new user, which is why the switch is treated as a restart.

The 4-week ladder

Tirzepatide reference schedules move up in roughly 2.5 mg steps, with about 4 weeks held at each step before any change. A typical ladder looks like this:

  • Weeks 1 to 4: 2.5 mg once weekly
  • Weeks 5 to 8: 5 mg once weekly
  • Weeks 9 to 12: 7.5 mg once weekly
  • Weeks 13 to 16: 10 mg once weekly
  • Then 12.5 mg, then 15 mg, each held about 4 weeks

The 4-week spacing is what makes each step gradual. A clinician decides whether and when to move up, and many people hold at a lower step rather than climbing to the top. The full reference ladder is laid out in the tirzepatide dosage chart.

Timing the switch

Because semaglutide is dosed once weekly, the simple reference approach is to place the first tirzepatide dose where the next semaglutide dose would have fallen, about 7 days after the last one. That keeps a steady weekly rhythm without doubling up. There is no overlap step in standard schedules; one molecule stops and the other begins on the following weekly slot.

For the practical side of injection day, tirzepatide injection day best time covers how people pick and keep a consistent day.

Worked unit math

Units depend entirely on concentration, which is mg per mL after mixing. Take a 10 mg vial reconstituted with 0.5 mL of bacteriostatic water. That is 20 mg/mL, or 0.2 mg per unit on a U-100 insulin syringe (since 100 units = 1 mL).

  • 2.5 mg dose: 2.5 / 0.2 = 12.5 units
  • 5 mg dose: 5 / 0.2 = 25 units
  • 7.5 mg dose: 7.5 / 0.2 = 37.5 units
  • 10 mg dose: 10 / 0.2 = 50 units

Change the water volume and every number shifts, so always recompute. Use the reconstitution calculator to set concentration, then the tirzepatide calculator to turn each ladder step into units. If you are new to reading the barrel, see how to read an insulin syringe for peptides.

Key takeaways

  • No mg-for-mg map: tirzepatide and semaglutide are different molecules
  • Standard restart is 2.5 mg once weekly, treated like a fresh start
  • Climb in roughly 2.5 mg steps, about 4 weeks per step
  • Time the first tirzepatide dose on the next weekly slot, no overlap
  • Recompute units whenever concentration changes

This is general reference information, not medical advice. Tirzepatide and semaglutide are research compounds not approved for self-directed human use, and any switch or dose decision belongs with a licensed clinician. See the disclaimer for more.

Try the Tirzepatide calculator

Open the calculator

Frequently asked questions

Is there an equivalent tirzepatide dose for my semaglutide dose?
No. The two are different molecules with different receptor targets, and reference labeling does not define a milligram conversion. Standard schedules restart tirzepatide at its own lowest step rather than matching your semaglutide number.
What is the usual starting tirzepatide dose when switching?
Reference protocols generally begin at 2.5 mg once weekly, the lowest tirzepatide step, even for someone already months into semaglutide. It is treated as an introduction dose, not a continuation.
How fast does the tirzepatide ladder go up?
Reference schedules move in roughly 2.5 mg increments with about 4 weeks held at each step. A clinician decides whether to climb, and many people hold at a lower step.
When should the first tirzepatide dose fall after stopping semaglutide?
Both are once weekly, so the simple reference approach places the first tirzepatide dose on the next weekly slot, about 7 days after the last semaglutide dose. Standard schedules do not overlap the two.
How many units is a 2.5 mg tirzepatide dose?
It depends on concentration. At 20 mg/mL (a 10 mg vial mixed with 0.5 mL water), 2.5 mg is 12.5 units on a U-100 syringe. Recompute with a tirzepatide calculator whenever your mixing volume changes.

Keep this calculation in your pocket

Stackr saves every vial you reconstitute, tracks doses remaining, and reminds you to reorder before you run out. The reference app for people who take their protocol seriously.

Educational tool only, not medical advice. Peptides are research chemicals, not for human consumption. Full disclaimer.